Leveraging Cognitive and Speech Ecological Momentary Assessment in Individuals With Phenylketonuria: Development and Usability Study of Cognitive Fluctuations in a Rare Disease Population

BackgroundPhenylketonuria (PKU) is a rare, hereditary disease that causes disruption in phenylalanine (Phe) metabolism. Despite early intervention, individuals with PKU may have difficulty in several different cognitive domains, including verbal fluency, processing speed, and...

Full description

Saved in:
Bibliographic Details
Main Authors: Shifali Singh, Lisa Kluen, Katelin Curtis, Raquel Norel, Carla Agurto, Elizabeth Grinspoon, Zoe Hawks, Shawn Christ, Susan Waisbren, Guillermo Cecchi, Laura Germine
Format: Article
Language:English
Published: JMIR Publications 2025-06-01
Series:JMIR Formative Research
Online Access:https://formative.jmir.org/2025/1/e63644
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849697042407882752
author Shifali Singh
Lisa Kluen
Katelin Curtis
Raquel Norel
Carla Agurto
Elizabeth Grinspoon
Zoe Hawks
Shawn Christ
Susan Waisbren
Guillermo Cecchi
Laura Germine
author_facet Shifali Singh
Lisa Kluen
Katelin Curtis
Raquel Norel
Carla Agurto
Elizabeth Grinspoon
Zoe Hawks
Shawn Christ
Susan Waisbren
Guillermo Cecchi
Laura Germine
author_sort Shifali Singh
collection DOAJ
description BackgroundPhenylketonuria (PKU) is a rare, hereditary disease that causes disruption in phenylalanine (Phe) metabolism. Despite early intervention, individuals with PKU may have difficulty in several different cognitive domains, including verbal fluency, processing speed, and executive functioning. ObjectiveThe overarching goal of this study is to characterize the relationships among cognition, speech, mood, and blood-based biomarkers (Phe, tyrosine) in individuals with early treated PKU. We describe our initial optimization pilot results that are guiding this study while establishing the feasibility and reliability of using ecological momentary assessment (EMA) in this clinical population. MethodsIn total, 20 adults with PKU were enrolled in this study between December 2022 and March 2023 through the National PKU Alliance. Of the total, 18 participants completed an extended baseline assessment followed by 6 EMAs over 1 month. The EMAs included digital cognitive tests measuring processing speed, sustained attention, and executive functioning, as well as speech (semantic fluency) and mood measures. Participants had 60 minutes to complete the assessment. ResultsCompletion rates of EMAs were above 70% (on average 4.78 out of 6 EMAs), with stable performances across baseline measures and EMAs. Between-person reliability (BPR) of the EMAs, representing the variance due to differences between individuals versus within individuals, is satisfactory with values close to (semantic fluency BPR: 0.7, sustained attention BPR: 0.72) or exceeding (processing speed: 0.93, executive functioning: 0.88) data collected from a large normative database (n=5039-10,703), as well as slightly below or matching a previous study using a clinical group (n=18). As applicable, within-person reliability was also computed; we demonstrated strong reliability for processing speed (0.87). A control analysis ensured that time of day (ie, morning, afternoon, and evening) did not impact performance; performance on tasks did not decrease if tested earlier versus later in the day (all P values >.09). Similarly, to assess variability in task performance over the course of all EMAs, the coefficient of variability was computed; 28% for the task measuring sustained attention, 37% for semantic fluency, 15.8% for the task measuring executive functioning, and 17.6% for processing speed. Performance appears more stable in tasks measuring processing speed and executive functioning than on tasks of sustained attention and semantic fluency. ConclusionsPreliminary results of this study demonstrate strong reliability of cognitive EMA, indicating that EMA is a promising tool for evaluating fluctuations in cognitive status in this population. Future work should refine and expand the utility of these digital tools, determine how variable EMA frequencies might better characterize changes in functioning as they relate to blood-based biomarkers, and validate a singular battery that could be rapidly administered at scale and in clinical trials to determine the progression of disease.
format Article
id doaj-art-edbc7ca4b93c4847b928c35d9e616c38
institution DOAJ
issn 2561-326X
language English
publishDate 2025-06-01
publisher JMIR Publications
record_format Article
series JMIR Formative Research
spelling doaj-art-edbc7ca4b93c4847b928c35d9e616c382025-08-20T03:19:17ZengJMIR PublicationsJMIR Formative Research2561-326X2025-06-019e6364410.2196/63644Leveraging Cognitive and Speech Ecological Momentary Assessment in Individuals With Phenylketonuria: Development and Usability Study of Cognitive Fluctuations in a Rare Disease PopulationShifali Singhhttps://orcid.org/0000-0003-1312-665XLisa Kluenhttps://orcid.org/0009-0007-3370-7060Katelin Curtishttps://orcid.org/0009-0002-6872-8738Raquel Norelhttps://orcid.org/0000-0001-7737-4172Carla Agurtohttps://orcid.org/0000-0002-0617-4488Elizabeth Grinspoonhttps://orcid.org/0000-0002-5608-8254Zoe Hawkshttps://orcid.org/0000-0002-3796-0289Shawn Christhttps://orcid.org/0000-0002-7206-528XSusan Waisbrenhttps://orcid.org/0000-0003-0013-700XGuillermo Cecchihttps://orcid.org/0000-0003-1013-8348Laura Germinehttps://orcid.org/0000-0001-8690-8412 BackgroundPhenylketonuria (PKU) is a rare, hereditary disease that causes disruption in phenylalanine (Phe) metabolism. Despite early intervention, individuals with PKU may have difficulty in several different cognitive domains, including verbal fluency, processing speed, and executive functioning. ObjectiveThe overarching goal of this study is to characterize the relationships among cognition, speech, mood, and blood-based biomarkers (Phe, tyrosine) in individuals with early treated PKU. We describe our initial optimization pilot results that are guiding this study while establishing the feasibility and reliability of using ecological momentary assessment (EMA) in this clinical population. MethodsIn total, 20 adults with PKU were enrolled in this study between December 2022 and March 2023 through the National PKU Alliance. Of the total, 18 participants completed an extended baseline assessment followed by 6 EMAs over 1 month. The EMAs included digital cognitive tests measuring processing speed, sustained attention, and executive functioning, as well as speech (semantic fluency) and mood measures. Participants had 60 minutes to complete the assessment. ResultsCompletion rates of EMAs were above 70% (on average 4.78 out of 6 EMAs), with stable performances across baseline measures and EMAs. Between-person reliability (BPR) of the EMAs, representing the variance due to differences between individuals versus within individuals, is satisfactory with values close to (semantic fluency BPR: 0.7, sustained attention BPR: 0.72) or exceeding (processing speed: 0.93, executive functioning: 0.88) data collected from a large normative database (n=5039-10,703), as well as slightly below or matching a previous study using a clinical group (n=18). As applicable, within-person reliability was also computed; we demonstrated strong reliability for processing speed (0.87). A control analysis ensured that time of day (ie, morning, afternoon, and evening) did not impact performance; performance on tasks did not decrease if tested earlier versus later in the day (all P values >.09). Similarly, to assess variability in task performance over the course of all EMAs, the coefficient of variability was computed; 28% for the task measuring sustained attention, 37% for semantic fluency, 15.8% for the task measuring executive functioning, and 17.6% for processing speed. Performance appears more stable in tasks measuring processing speed and executive functioning than on tasks of sustained attention and semantic fluency. ConclusionsPreliminary results of this study demonstrate strong reliability of cognitive EMA, indicating that EMA is a promising tool for evaluating fluctuations in cognitive status in this population. Future work should refine and expand the utility of these digital tools, determine how variable EMA frequencies might better characterize changes in functioning as they relate to blood-based biomarkers, and validate a singular battery that could be rapidly administered at scale and in clinical trials to determine the progression of disease.https://formative.jmir.org/2025/1/e63644
spellingShingle Shifali Singh
Lisa Kluen
Katelin Curtis
Raquel Norel
Carla Agurto
Elizabeth Grinspoon
Zoe Hawks
Shawn Christ
Susan Waisbren
Guillermo Cecchi
Laura Germine
Leveraging Cognitive and Speech Ecological Momentary Assessment in Individuals With Phenylketonuria: Development and Usability Study of Cognitive Fluctuations in a Rare Disease Population
JMIR Formative Research
title Leveraging Cognitive and Speech Ecological Momentary Assessment in Individuals With Phenylketonuria: Development and Usability Study of Cognitive Fluctuations in a Rare Disease Population
title_full Leveraging Cognitive and Speech Ecological Momentary Assessment in Individuals With Phenylketonuria: Development and Usability Study of Cognitive Fluctuations in a Rare Disease Population
title_fullStr Leveraging Cognitive and Speech Ecological Momentary Assessment in Individuals With Phenylketonuria: Development and Usability Study of Cognitive Fluctuations in a Rare Disease Population
title_full_unstemmed Leveraging Cognitive and Speech Ecological Momentary Assessment in Individuals With Phenylketonuria: Development and Usability Study of Cognitive Fluctuations in a Rare Disease Population
title_short Leveraging Cognitive and Speech Ecological Momentary Assessment in Individuals With Phenylketonuria: Development and Usability Study of Cognitive Fluctuations in a Rare Disease Population
title_sort leveraging cognitive and speech ecological momentary assessment in individuals with phenylketonuria development and usability study of cognitive fluctuations in a rare disease population
url https://formative.jmir.org/2025/1/e63644
work_keys_str_mv AT shifalisingh leveragingcognitiveandspeechecologicalmomentaryassessmentinindividualswithphenylketonuriadevelopmentandusabilitystudyofcognitivefluctuationsinararediseasepopulation
AT lisakluen leveragingcognitiveandspeechecologicalmomentaryassessmentinindividualswithphenylketonuriadevelopmentandusabilitystudyofcognitivefluctuationsinararediseasepopulation
AT katelincurtis leveragingcognitiveandspeechecologicalmomentaryassessmentinindividualswithphenylketonuriadevelopmentandusabilitystudyofcognitivefluctuationsinararediseasepopulation
AT raquelnorel leveragingcognitiveandspeechecologicalmomentaryassessmentinindividualswithphenylketonuriadevelopmentandusabilitystudyofcognitivefluctuationsinararediseasepopulation
AT carlaagurto leveragingcognitiveandspeechecologicalmomentaryassessmentinindividualswithphenylketonuriadevelopmentandusabilitystudyofcognitivefluctuationsinararediseasepopulation
AT elizabethgrinspoon leveragingcognitiveandspeechecologicalmomentaryassessmentinindividualswithphenylketonuriadevelopmentandusabilitystudyofcognitivefluctuationsinararediseasepopulation
AT zoehawks leveragingcognitiveandspeechecologicalmomentaryassessmentinindividualswithphenylketonuriadevelopmentandusabilitystudyofcognitivefluctuationsinararediseasepopulation
AT shawnchrist leveragingcognitiveandspeechecologicalmomentaryassessmentinindividualswithphenylketonuriadevelopmentandusabilitystudyofcognitivefluctuationsinararediseasepopulation
AT susanwaisbren leveragingcognitiveandspeechecologicalmomentaryassessmentinindividualswithphenylketonuriadevelopmentandusabilitystudyofcognitivefluctuationsinararediseasepopulation
AT guillermocecchi leveragingcognitiveandspeechecologicalmomentaryassessmentinindividualswithphenylketonuriadevelopmentandusabilitystudyofcognitivefluctuationsinararediseasepopulation
AT lauragermine leveragingcognitiveandspeechecologicalmomentaryassessmentinindividualswithphenylketonuriadevelopmentandusabilitystudyofcognitivefluctuationsinararediseasepopulation